SL BIGEN is a R&D-oriented company, with an aim to Save patient's Lives By Bio-Genetic ENgineering. SL BIGEN is developing (i) the first-in-class mesenchymal stem cell line engineered to express disease-specific therapeutic genes and (ii) the multi-engineered natural killer cell line expressing the fourth generation chimeric antigen receptors. Our therapeutic areas include cancer and neurodegenerative diseases.
| Website | http://www.slbigen.com |
| Revenue | $2 million |
| Employees | View employees |
| Phone | +82 31-628-2188 |
| Industry | Business Services General, Business Services |
| Competitors | Bayer, 陶氏化学(中国)投资有限公司, Syngenta, Corteva Agriscience, DuPont Pioneer, Alellyx Applied Genomics Ltda, Nufarm, ADAMA Ltd., Valent U.S.A. LLC, Marrone Bio Innovations +29 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Sl Bigen employee's phone or email?
Sl Bigen Questions
The Sl Bigen annual revenue was $2 million in 2026.
Sl Bigen is based in Seongnam, Kyonggi-do.
The NAICS codes for Sl Bigen are [54, 541, 541714, 54171, 5417].
The SIC codes for Sl Bigen are [873, 87].
